Remedy Robotics

Remedy Robotics develops the world's first remotely operated endovascular robotic system that enables clinicians to perform minimally invasive cardiovascular interventions, including stroke and heart attack treatments, remotely with AI-enabled software and proprietary hardware.

  • AI/ML
  • Deep Tech
  • Robotics
  • Digital Health
  • Medtech
  • Healthcare & Life Sciences

1

Round

1

Industry

5

Tags

Nov 16, 2026

Latest raise

Funding activity · 1 round

Raise timeline

  1. Nov 16, 2026

    $62M

    Series B

    Led by DCVC

    • Skip Capital
    • UC Investments
    • KdT Ventures
    • Blackbird
    • Tony Fadell’s Build Collective
    • DCVC
    • Hostplus
    • Divergent Capital

    Article coming soon.

Pricing

Research Remedy Robotics — then scale the playbook

Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.

Enterprise

Custom pricing for unlimited scale. Let's talk.

Contact sales

Growth plan

For individuals and small teams getting started with AI buyer intelligence.

$149

/month

Features

  • Access to core AI adoption signals
  • 3–5 curated slices per week
  • 30–60 companies / week
  • AI Adoption Score
  • Deal-ready insights (why + pitch angle)
  • Basic filters (recency, slice, score)
  • CSV export
Most popular

Pro plan

For outbound teams and agencies that need more coverage and faster signal cadence.

$249

/month

Features

  • Everything in Growth, plus:
  • Full access to all slices
  • 60–120 companies / week
  • Higher-frequency signal updates
  • Priority / early signals (before Growth)
  • Advanced filters (industry, size, use case)
  • Deeper company insights
  • Faster export + bulk workflows

Act on this raise

See if Remedy Robotics is moving on AI

Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.

© 2026 VeilStrat. All rights reserved.All systems operational